NS-398, a Cyclooxygenase-2-specific Inhibitor, Delays Skeletal Muscle Healing by Decreasing Regeneration and Promoting Fibrosis

Overview

Journal Am J Pathol

Publisher Elsevier

Specialty Pathology

Date 2005 Sep 30

PMID 16192645

Citations 51

Authors

Wei Shen

Yong Li

Ying Tang

James Cummins

Johnny Huard

Affiliations

Soon will be listed here.

Abstract

Nonsteroidal anti-inflammatory drugs are often prescribed after muscle injury. However, the effect of nonsteroidal anti-inflammatory drugs on muscle healing remains primarily controversial. To further examine the validity of using these drugs after muscle injury, we investigated the working mechanism of NS-398, a cyclooxygenase-2-specific inhibitor. In vitro experiments showed that NS-398 inhibited the proliferation and maturation of differentiated myogenic precursor cells, suggesting a detrimental effect on skeletal muscle healing. Using a mouse laceration model, we analyzed the in vivo effect of NS-398 on skeletal muscle healing at time points up to 4 weeks after injury. The in vivo results revealed delayed muscle regeneration at early time points after injury in the NS-398-treated mice. Compared to controls, lacerated muscles treated with NS-398 expressed higher levels of transforming growth factor-beta1, which corresponded with increased fibrosis. In addition, transforming growth factor-beta1 co-localized with myostatin, a negative regulator of skeletal muscle growth. We also found reduced neutrophil and macrophage infiltration in treated muscles, indicating that the delayed skeletal muscle healing observed after NS-398 treatment could be influenced by the anti-inflammatory effect of NS-398. Our findings suggest that the use of cyclooxygenase-2-specific inhibitors to treat skeletal muscle injuries warrants caution because they may interfere with muscle healing.

Citing Articles

Role of macrophages during skeletal muscle regeneration and hypertrophy-Implications for immunomodulatory strategies.

Bernard C, Zavoriti A, Pucelle Q, Chazaud B, Gondin J Physiol Rep. 2022; 10(19):e15480.

PMID: 36200266 PMC: 9535344. DOI: 10.14814/phy2.15480.

Molecular Genetics and Cytotoxic Responses to Titanium Diboride and Zinc Borate Nanoparticles on Cultured Human Primary Alveolar Epithelial Cells.

Turkez H, Arslan M, Tatar A, Ozdemir O, Sonmez E, Cadirci K Materials (Basel). 2022; 15(7).

PMID: 35407693 PMC: 9000154. DOI: 10.3390/ma15072359.

Fibrosis following Acute Skeletal Muscle Injury: Mitigation and Reversal Potential in the Clinic.

Gardner T, Kenter K, Li Y J Sports Med (Hindawi Publ Corp). 2020; 2020:7059057.

PMID: 33376749 PMC: 7745048. DOI: 10.1155/2020/7059057.

Skeletal muscle healing by M1-like macrophages produced by transient expression of exogenous GM-CSF.

Martins L, Gallo C, Bandeira Honda T, Alves P, Stilhano R, Santoro Rosa D Stem Cell Res Ther. 2020; 11(1):473.

PMID: 33158459 PMC: 7648431. DOI: 10.1186/s13287-020-01992-1.

Dose-dependent pro- or anti-fibrotic responses of endometriotic stromal cells to interleukin-1β and tumor necrosis factor α.

Matsuzaki S, Pouly J, Canis M Sci Rep. 2020; 10(1):9467.

PMID: 32528066 PMC: 7289797. DOI: 10.1038/s41598-020-66298-x.

References

Wolfman N, McPherron A, Pappano W, Davies M, Song K, Tomkinson K . Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases. Proc Natl Acad Sci U S A. 2003; 100(26):15842-6. PMC: 307655. DOI: 10.1073/pnas.2534946100. View

Smith J, Grisham M, Granger D, Korthuis R . Free radical defense mechanisms and neutrophil infiltration in postischemic skeletal muscle. Am J Physiol. 1989; 256(3 Pt 2):H789-93. DOI: 10.1152/ajpheart.1989.256.3.H789. View

Bondesen B, Mills S, Kegley K, Pavlath G . The COX-2 pathway is essential during early stages of skeletal muscle regeneration. Am J Physiol Cell Physiol. 2004; 287(2):C475-83. DOI: 10.1152/ajpcell.00088.2004. View

Mendias C, Tatsumi R, Allen R . Role of cyclooxygenase-1 and -2 in satellite cell proliferation, differentiation, and fusion. Muscle Nerve. 2004; 30(4):497-500. DOI: 10.1002/mus.20102. View

Simchowitz L, Mehta J, Spilberg I . Chemotactic factor-induced generation of superoxide radicals by human neutrophils: effect of metabolic inhibitors and antiinflammatory drugs. Arthritis Rheum. 1979; 22(7):755-63. DOI: 10.1002/art.1780220711. View

Camargo F, Green R, Capetanaki Y, Jackson K, Goodell M, Capetenaki Y . Single hematopoietic stem cells generate skeletal muscle through myeloid intermediates. Nat Med. 2003; 9(12):1520-7. DOI: 10.1038/nm963. View

Shanmugasundaram T . Post-injection fibrosis of skeletal muscle: a clinical problem. A personal series of 169 cases. Int Orthop. 1980; 4(1):31-7. DOI: 10.1007/BF00266601. View

Ault K, Springer T . Cross-reaction of a rat-anti-mouse phagocyte-specific monoclonal antibody (anti-Mac-1) with human monocytes and natural killer cells. J Immunol. 1981; 126(1):359-64. View

Austyn J, Gordon S . F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol. 1981; 11(10):805-15. DOI: 10.1002/eji.1830111013. View

10.

Hammerschmidt D, Flynn P, Coppo P, Skubitz K, JACOB H . Synergy among agents inhibiting granulocyte aggregation. Inflammation. 1982; 6(2):169-76. DOI: 10.1007/BF00916241. View

11.

Landay A, Gartland G, Clement L . Characterization of a phenotypically distinct subpopulation of Leu-2+ cells that suppresses T cell proliferative responses. J Immunol. 1983; 131(6):2757-61. View

12.

Kaplan H, Edelson H, Korchak H, GIVEN W, Abramson S, Weissmann G . Effects of non-steroidal anti-inflammatory agents on human neutrophil functions in vitro and in vivo. Biochem Pharmacol. 1984; 33(3):371-8. DOI: 10.1016/0006-2952(84)90228-4. View

13.

Dijkstra C, Dopp E, Joling P, Kraal G . The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology. 1985; 54(3):589-99. PMC: 1453512. View

14.

Almekinders L, Gilbert J . Healing of experimental muscle strains and the effects of nonsteroidal antiinflammatory medication. Am J Sports Med. 1986; 14(4):303-8. DOI: 10.1177/036354658601400411. View

15.

Jolly S, Kane W, Hook B, Abrams G, Kunkel S, Lucchesi B . Reduction of myocardial infarct size by neutrophil depletion: effect of duration of occlusion. Am Heart J. 1986; 112(4):682-90. DOI: 10.1016/0002-8703(86)90461-8. View

16.

Hill M, Brown W . Myosin heavy chain expression in human muscle cocultured with mouse spinal cord. J Neurol Sci. 1989; 90(2):167-77. DOI: 10.1016/0022-510x(89)90099-3. View

17.

Hill M, Brown W . Immunocytochemical demonstration of myosin heavy chain expression in human muscle. J Neurol Sci. 1989; 91(1-2):71-8. DOI: 10.1016/0022-510x(89)90076-2. View

18.

Kishimoto T, Jutila M, Berg E, Butcher E . Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. Science. 1989; 245(4923):1238-41. DOI: 10.1126/science.2551036. View

19.

Hirschowitz B, Lanas A . NSAID association with gastrointestinal bleeding and peptic ulcer. Agents Actions Suppl. 1991; 35:93-101. View

20.

Davis C, Harris J, Nicholson L . Myosin isoform transitions and physiological properties of regenerated and re-innervated soleus muscles of the rat. Neuromuscul Disord. 1991; 1(6):411-21. DOI: 10.1016/0960-8966(91)90004-c. View